A metabolic interaction in vivo between cannabidiol and Δ1‐tetrahydrocannabinol

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|45|2|375-377

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.45, Iss.2, 1972-06, pp. : 375-377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabidiol does not reverse THC hypothermia

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 7, 2015-04 ,pp. : 1783-1791

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy

By  

EPILEPSIA, Vol. 56, Iss. 8, 2015-08 ,pp. : 1246-1251

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanistic studies (in vivo and ex vivo) of CBD and THCV

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 3, 2015-02 ,pp. : 737-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delta9‐tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 587-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence of CYP3A Allosterism In Vivo: Analysis of Interaction Between Fluconazole and Midazolam

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 442-449

John Wiley & Sons Inc

Access to resources Recommend Favorite